» Articles » PMID: 35956214

I-FABP As a Potential Marker for Intestinal Barrier Loss in Porcine Polytrauma

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Aug 12
PMID 35956214
Authors
Affiliations
Soon will be listed here.
Abstract

Polytrauma and concomitant hemorrhagic shock can lead to intestinal damage and subsequent multiple organ dysfunction syndrome. The intestinal fatty acid-binding protein (I-FABP) is expressed in the intestine and appears quickly in the circulation after intestinal epithelial cell damage. This porcine animal study investigates the I-FABP dynamics in plasma and urine after polytrauma. Furthermore, it evaluates to what extent I-FABP can also act as a marker of intestinal damage in a porcine polytrauma model. Eight pigs (Sus scrofa) were subjected to polytrauma which consisted of lung contusion, tibial fracture, liver laceration, and hemorrhagic shock followed by blood and fluid resuscitation and fracture fixation with an external fixator. Eight sham animals were identically instrumented but not injured. Afterwards, intensive care treatment including mechanical ventilation for 72 h followed. I-FABP levels in blood and urine were determined by ELISA. In addition, immunohistological staining for I-FABP, active caspase-3 and myeloperoxidase were performed after 72 h. Plasma and urine I-FABP levels were significantly increased shortly after trauma. I-FABP expression in intestinal tissue showed significantly lower expression in polytraumatized animals vs. sham. Caspase-3 and myeloperoxidase expression in the immunohistological examination were significantly higher in the jejunum and ileum of polytraumatized animals compared to sham animals. This study confirms a loss of intestinal barrier after polytrauma which is indicated by increased I-FABP levels in plasma and urine as well as decreased I-FABP levels in immunohistological staining of the intestine.

Citing Articles

The Effects of Dietary Supplementation on Gut Microbiota Composition and Gut Health in Aged Labrador Retrievers.

Cui Y, Li D, Zhang M, Liu P, Wang H, Li Y Animals (Basel). 2024; 14(12).

PMID: 38929332 PMC: 11200521. DOI: 10.3390/ani14121713.


I-FABP protein/mRNA and IL-6 as biomarkers of intestinal barrier dysfunction in neonates with necrotizing enterocolitis and SPF BALB/c mouse models.

Chen J, Yan Z, Lin Z, Fan Y, Bao X, Chen X J Int Med Res. 2024; 52(6):3000605241254788.

PMID: 38867509 PMC: 11179468. DOI: 10.1177/03000605241254788.


Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of salidroside on intestine ischemia reperfusion.

Chen F, Chai Y, Zhang F, Liu Y, Zhang Y, Shi Y Biosci Rep. 2023; 43(8).

PMID: 37530723 PMC: 10462912. DOI: 10.1042/BSR20230539.


Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome.

Lv R, Liu X, Zhang Y, Dong N, Wang X, He Y Signal Transduct Target Ther. 2023; 8(1):218.

PMID: 37230968 PMC: 10211313. DOI: 10.1038/s41392-023-01496-3.

References
1.
Matute-Bello G, Frevert C, Martin T . Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008; 295(3):L379-99. PMC: 2536793. DOI: 10.1152/ajplung.00010.2008. View

2.
. Advanced trauma life support (ATLS®): the ninth edition. J Trauma Acute Care Surg. 2013; 74(5):1363-6. DOI: 10.1097/TA.0b013e31828b82f5. View

3.
Sturm R, Haag F, Janicova A, Xu B, Vollrath J, Bundkirchen K . Acute alcohol consumption increases systemic endotoxin bioactivity for days in healthy volunteers-with reduced intestinal barrier loss in female. Eur J Trauma Emerg Surg. 2021; 48(3):1569-1577. PMC: 9192383. DOI: 10.1007/s00068-021-01666-4. View

4.
Mittal R, Coopersmith C . Redefining the gut as the motor of critical illness. Trends Mol Med. 2013; 20(4):214-23. PMC: 3959633. DOI: 10.1016/j.molmed.2013.08.004. View

5.
Evennett N, Petrov M, Mittal A, Windsor J . Systematic review and pooled estimates for the diagnostic accuracy of serological markers for intestinal ischemia. World J Surg. 2009; 33(7):1374-83. DOI: 10.1007/s00268-009-0074-7. View